Log in
Registereverolimus [Regulatives / Guidelines]
posted by Helmut 
– Vienna, Austria, 2013-10-03 16:07 (4653 d 03:43 ago) – Posting: # 11599
Views: 6,047
Hi Anu,
See this post for APIs currently considered NTIDs in different regions. Since everolimus is a derivative of sirolimus I would ask the respective agency about their current thinking.
❝ Is Everolimus 0.75 mg (Zortress) is under NTI (Narrow Therapeutic Index)?
See this post for APIs currently considered NTIDs in different regions. Since everolimus is a derivative of sirolimus I would ask the respective agency about their current thinking.
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
Helmut Schütz
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Complete thread:
- NTI Anu 2013-10-03 11:00
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- everolimusHelmut 2013-10-03 14:07
- everolimus Anu 2013-10-04 06:22
- No list of NTIDs in the EU Helmut 2013-10-04 16:03
- everolimus Anu 2013-10-04 06:22
- NTI drgunasakaran1 2013-10-03 16:09
- everolimusHelmut 2013-10-03 14:07
Ing. Helmut Schütz